Freek Cox

3.1k total citations · 2 hit papers
24 papers, 2.1k citations indexed

About

Freek Cox is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Freek Cox has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Freek Cox's work include Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers) and Viral gastroenteritis research and epidemiology (6 papers). Freek Cox is often cited by papers focused on Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers) and Viral gastroenteritis research and epidemiology (6 papers). Freek Cox collaborates with scholars based in Netherlands, United States and Germany. Freek Cox's co-authors include Jaap Goudsmit, Leo L. M. Poon, Malik Peiris, Mandy Jongeneelen, John de Kruif, Lisette A. H. M. Cornelissen, Jan ter Meulen, Mark Throsby, Wouter Koudstaal and Martin H. Koldijk and has published in prestigious journals such as Science, Nature Communications and PLoS ONE.

In The Last Decade

Freek Cox

24 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

2011 660 citations Damian C. Ekiert, Robert H. Friesen et al. Science profile →
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

2008 596 citations Mark Throsby, Mandy Jongeneelen et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Freek Cox Netherlands	13	1.3k	766	637	511	491	24	2.1k
Carol D. Weiss United States	27	775 0.6×	1.2k 1.6×	756 1.2×	398 0.8×	669 1.4×	65	2.6k
Kanetsu Sugawara Japan	30	2.0k 1.5×	488 0.6×	599 0.9×	404 0.8×	798 1.6×	82	2.4k
Seth J. Zost United States	14	897 0.7×	1.7k 2.2×	451 0.7×	349 0.7×	713 1.5×	20	2.5k
Yasushi Muraki Japan	26	1.3k 1.0×	421 0.5×	404 0.6×	201 0.4×	500 1.0×	79	1.7k
Rodney S. Daniels United Kingdom	23	2.0k 1.6×	684 0.9×	484 0.8×	256 0.5×	773 1.6×	53	2.5k
Jens C. Krause United States	17	1.5k 1.2×	483 0.6×	658 1.0×	401 0.8×	481 1.0×	20	1.9k
Othmar G. Engelhardt United Kingdom	25	2.0k 1.6×	766 1.0×	768 1.2×	174 0.3×	831 1.7×	58	2.6k
Koji Ishii Japan	31	1.5k 1.2×	928 1.2×	279 0.4×	413 0.8×	767 1.6×	118	3.4k
David C. Flyer United States	24	659 0.5×	795 1.0×	714 1.1×	167 0.3×	336 0.7×	45	1.9k
Lisette A. H. M. Cornelissen Netherlands	13	1.3k 1.0×	696 0.9×	574 0.9×	411 0.8×	394 0.8×	13	2.0k

Countries citing papers authored by Freek Cox

Since Specialization

Citations

This map shows the geographic impact of Freek Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freek Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freek Cox more than expected).

Fields of papers citing papers by Freek Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Freek Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freek Cox. The network helps show where Freek Cox may publish in the future.

Co-authorship network of co-authors of Freek Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Freek Cox. A scholar is included among the top collaborators of Freek Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freek Cox. Freek Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bakkers, Mark J. G., Freek Cox, Annemart Koornneef, et al.. (2024). A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses. Nature Microbiology. 9(12). 3254–3267. 7 indexed citations

Langedijk, Johannes P. M., Freek Cox, Nicole V. Johnson, et al.. (2024). Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein. Nature Communications. 15(1). 4629–4629. 4 indexed citations

Martinot, Amanda J., Freek Cox, Peter Abbink, et al.. (2024). Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection. npj Vaccines. 9(1). 157–157. 1 indexed citations

Cox, Freek, et al.. (2024). Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G. Vaccines. 12(3). 294–294. 7 indexed citations

Saeland, Eiríkur, Leslie van der Fits, Lisanne Tettero, et al.. (2023). Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models. npj Vaccines. 8(1). 45–45. 11 indexed citations

Cox, Freek, Eiríkur Saeland, Lisanne Tettero, et al.. (2023). RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models. Vaccines. 11(3). 672–672. 6 indexed citations

Amssoms, Katie, Freek Cox, Ellen Van Gulck, et al.. (2019). Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics. 11(10). 510–510. 1 indexed citations

Cox, Freek, Leslie van der Fits, Peter Abbink, et al.. (2018). Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge. PLoS ONE. 13(8). e0202820–e0202820. 44 indexed citations

Cox, Freek, Ted Kwaks, Boerries Brandenburg, et al.. (2016). HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids. Frontiers in Immunology. 7. 399–399. 48 indexed citations

10.

Cox, Freek, Eiríkur Saeland, Martin H. Koldijk, et al.. (2015). Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine. Virology Journal. 12(1). 210–210. 6 indexed citations

11.

Cox, Freek, Jeroen Tolboom, Liesbeth Dekking, et al.. (2015). Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge. PLoS ONE. 10(9). e0135723–e0135723. 7 indexed citations

12.

Cox, Freek, Jeroen Huizingh, Jeroen Tolboom, et al.. (2015). Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells. PLoS ONE. 10(12). e0145243–e0145243. 13 indexed citations

13.

Leahy, Sinead C., William J. Kelly, Duan Li, et al.. (2013). The Complete Genome Sequence of Methanobrevibacter sp. AbM4. Standards in Genomic Sciences. 8(2). 215–227. 41 indexed citations

14.

Ekiert, Damian C., Robert H. Friesen, Gira Bhabha, et al.. (2011). A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses. Science. 333(6044). 843–850. 660 indexed citations breakdown →

15.

Kruif, John de, Arjen Kramer, Therèse Visser, et al.. (2009). Human Immunoglobulin Repertoires against Tetanus Toxoid Contain a Large and Diverse Fraction of High-Affinity Promiscuous VH Genes. Journal of Molecular Biology. 387(3). 548–558. 19 indexed citations

16.

Throsby, Mark, Mandy Jongeneelen, Leo L. M. Poon, et al.. (2008). Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells. PLoS ONE. 3(12). e3942–e3942. 596 indexed citations breakdown →

17.

Meulen, Jan ter, Edward N. van den Brink, Leo L. M. Poon, et al.. (2006). Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants. PLoS Medicine. 3(7). e237–e237. 366 indexed citations

18.

Cox, Freek, Pauline M.L. Rood, Mark Throsby, et al.. (2005). Affinity ranking of antibodies using flow cytometry: Application in antibody phage display-based target discovery. Journal of Immunological Methods. 302(1-2). 68–77. 24 indexed citations

19.

Bijl, Nora, Freek Cox, Mark Throsby, et al.. (2004). A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry. European Journal of Cancer. 41(1). 178–187. 50 indexed citations

20.

Liew, F Y, et al.. (1991). TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis.. PubMed. 74(2). 304–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact